Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Direktor, Zentrum für Kinder- und Jugendmedizin
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)In: Blood Advances Jg. 8 (2024) Nr. 19, S. 5100 - 5111Online Volltext: dx.doi.org/ (Open Access)
-
Die ambulant-aufsuchende Versorgung von an Krebs erkrankten Kindern aus Sicht der Erziehungsberechtigten : Eine qualitative EvaluationsstudieIn: Klinische Pädiatrie Jg. 236 (2024) Nr. 3, S. 165 - 172Online Volltext: dx.doi.org/
-
Feasibility, efficacy, and safety of animal-assisted activities with visiting dogs in inpatient pediatric oncologyIn: World Journal of Pediatrics (WJP) Jg. 20 (2024) Nr. 9, S. 915 - 924Online Volltext: dx.doi.org/ (Open Access)
-
Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndromeIn: Pediatric Blood and Cancer Jg. 71 (2024) Nr. 9, e31141Online Volltext: dx.doi.org/ (Open Access)
-
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children : A substudy of 2 phase 2 trialsIn: British Journal of Clinical Pharmacology (BJCP) (2024) in pressOnline Volltext: dx.doi.org/
-
Kardiovaskuläre Toxizität der Therapie onkologischer Erkrankungen bei Kindern und Jugendlichen : Positionspapier zu Aspekten der kardiologischen Betreuung und NachsorgeIn: Monatsschrift Kinderheilkunde Jg. 172 (2024) Nr. Suppl. 1, S. 14 - 42Online Volltext: dx.doi.org/ (Open Access)
-
Netzwerk ActiveOncoKids : Zentralisierte Sportberatung im deutschsprachigen Raum für Kinder, Jugendliche und junge Erwachsene in allen onkologischen BehandlungsphasenIn: Klinische Pädiatrie (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Osteosarcomas in retinoblastoma-survivors : A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)In: EJC Paediatric Oncology Jg. 3 (2024) 100158Online Volltext: dx.doi.org/ (Open Access)
-
Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemiaIn: Leukemia Jg. 38 (2024) Nr. 3, S. 538 - 544Online Volltext: dx.doi.org/ (Open Access)
-
Perspektiven von Familien mit (schwer-)kranken Kindern und Jugendlichen in Niedersachsen : Versorgung und Unterstützung im Fokus-Analyse der aktuellen Situation und möglicher UnterstützungsangeboteIn: Das Gesundheitswesen (2024) in pressOnline Volltext: dx.doi.org/
-
Pflegerische und ärztlich delegierbare Maßnahmen bei päd.-onkologischen Patienten als ambulant aufsuchende Versorgung : Das Projekt KIKHomeCareIn: Klinische Pädiatrie (2024) in pressOnline Volltext: dx.doi.org/
-
Rearrangements involving 11q23.3/KMT2A in adult AML : mutational landscape and prognostic implications – a HARMONY studyIn: Leukemia Jg. 38 (2024) Nr. 9, S. 1929 - 1937Online Volltext: dx.doi.org/ (Open Access)
-
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasmsIn: Nature Communications Jg. 15 (2024) Nr. 1, 6025Online Volltext: dx.doi.org/ (Open Access)
-
Severely reduced physical performance is already present at the time of admission for stem cell transplantationIn: BMJ Open Sport & Exercise Medicine Jg. 10 (2024) Nr. 2, e001907Online Volltext: dx.doi.org/ (Open Access)
-
The PedAL/EuPAL Project : A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid LeukemiaIn: Cancers Jg. 16 (2024) Nr. 1, 78Online Volltext: dx.doi.org/ (Open Access)
-
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease : A randomized phase 2 trialIn: Bone Marrow Transplantation Jg. 59 (2024) Nr. 1, S. 107 - 116Online Volltext: dx.doi.org/ (Open Access)
-
Y-box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts : implications for acute myeloid leukaemiaIn: Journal of Extracellular Vesicles (JEV) Jg. 13 (2024) Nr. 3, e12417Online Volltext: dx.doi.org/ (Open Access)
-
A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutationsIn: Human Molecular Genetics Jg. 32 (2023) Nr. 11, S. 1836 - 1849Online Volltext: dx.doi.org/
-
Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis ToolboxIn: Cell Genomics Jg. 3 (2023) Nr. 9, 100389Online Volltext: dx.doi.org/ (Open Access)
-
Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow stem cellsIn: Cell Discovery Jg. 9 (2023) Nr. 1, 12Online Volltext: dx.doi.org/ (Open Access)
-
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia : An I-BFM Study Group collaborationIn: Blood Advances Jg. 7 (2023) Nr. 6, S. 1045 - 1055Online Volltext: dx.doi.org/ (Open Access)
-
Is an Exercise Program for Pediatric Cancer Patients in Palliative Care Feasible and Supportive? : A Case SeriesIn: Children Jg. 10 (2023) Nr. 2, 318Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Kardiologische Betreuung und Nachsorge bei Kindern und Jugendlichen nach onkologischer Therapie : Kurzfassung des Positionspapiers zur kardiovaskulären Toxizität der Therapie onkologischer Erkrankungen des Kindes- und JugendaltersIn: Monatsschrift Kinderheilkunde Jg. 171 (2023) Nr. 10, S. 926 - 928Online Volltext: dx.doi.org/
-
Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15In: iScience Jg. 26 (2023) Nr. 10, 107844Online Volltext: dx.doi.org/ (Open Access)
-
Physical activity in 9–15 year-old pediatric cancer survivors compared to a nationwide sampleIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 4719 - 4729Online Volltext: dx.doi.org/ (Open Access)
-
RUNX1 isoform disequilibrium promotes the development of trisomy 21–associated myeloid leukemiaIn: Blood Jg. 141 (2023) Nr. 10, S. 1105 - 1118Online Volltext: dx.doi.org/ (Open Access)
-
RUNX1 mutation has no prognostic significance in paediatric AML : A retrospective study of the AML-BFM study groupIn: Leukemia Jg. 37 (2023) Nr. 7, S. 1435 - 1443Online Volltext: dx.doi.org/ (Open Access)
-
Single Molecule Localization Microscopy for Studying Small Extracellular VesiclesIn: Small Jg. 19 (2023) Nr. 12, 2205030Online Volltext: dx.doi.org/ (Open Access)
-
Understanding WT1 Alterations and Expression Profiles in Hematological MalignanciesIn: Cancers Jg. 15 (2023) Nr. 13, 3491Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
DNA in extracellular vesicles : From evolution to its current application in health and diseaseIn: Cell and Bioscience Jg. 12 (2022) Nr. 1, 37Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Design and Evaluation of an Outdoor Exercise Program for Pediatric Cancer SurvivorsIn: Children Jg. 9 (2022) Nr. 8, 1117Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Effects of an Exercise Intervention on Gait Function in Young Survivors of Osteosarcoma with Megaendoprosthesis of the Lower Extremity : Results from the Pilot Randomized Controlled Trial proGAITIn: Current Oncology Jg. 29 (2022) Nr. 10, S. 7754 - 7767Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Efficient Small Extracellular Vesicles (EV) Isolation Method and Evaluation of EV-Associated DNA Role in Cell–Cell Communication in CancerIn: Cancers Jg. 14 (2022) Nr. 9, 2068Online Volltext: dx.doi.org/ (Open Access)
-
Ein individualisiertes Bewegungsprogramm für kinderonkologische Patienten in palliativen Situationen mithilfe von HausbesuchenIn: Bewegungstherapie und Gesundheitssport B&G Jg. 38 (2022) Nr. 05, S. 235 - 240Online Volltext: dx.doi.org/
-
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological MalignanciesIn: Frontiers in Immunology Jg. 13 (2022) 847008Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by warIn: The Lancet Haematology Jg. 9 (2022) Nr. 9, S. e645 - e647Online Volltext: dx.doi.org/ (Open Access)
-
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDSIn: Haematologica / The Hematology Journal Jg. 107 (2022) Nr. 3, S. 759 - 4764Online Volltext: dx.doi.org/ (Open Access)
-
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia : Results from a phase II trialIn: Leukemia Jg. 36 (2022) Nr. 6, S. 1516 - 1524Online Volltext: dx.doi.org/ (Open Access)
-
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AMLIn: Frontiers in Pediatrics Jg. 10 (2022) 1046586Online Volltext: dx.doi.org/ (Open Access)
-
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients : A Retrospective Study by the I-BFM Study GroupIn: Biomedicines Jg. 10 (2022) Nr. 7, 1530Online Volltext: dx.doi.org/ (Open Access)
-
Network Oncolgy Specialist Advisory Service : A Survey of the Psychosocial Situation of Long Term Cancer Survivors During Childhood or Adolescents
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung, 1-4. Juni 2022, Wilsede,In: Klinische Pädiatrie Jg. 234 (2022) Nr. 3, 34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung, S. 138 - 145Online Volltext: dx.doi.org/ -
Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid LeukemiaIn: Cancers Jg. 14 (2022) Nr. 9, 2058Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Pediatric Acute Myeloid Leukemia : Past, Present, and FutureIn: Journal of Clinical Medicine (JCM) Jg. 11 (2022) Nr. 3, 504Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia : A retrospective cohort study of the Relapsed AML 2001/01 StudyIn: Pediatric Blood and Cancer Jg. 69 (2022) Nr. 1, e29341Online Volltext: dx.doi.org/
-
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesIn: Scientific Reports Jg. 12 (2022) Nr. 1, 9762Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesisIn: Blood Jg. 139 (2022) Nr. 5, S. 651 - 665Online Volltext: dx.doi.org/ (Open Access)
-
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol DevelopmentIn: Clinical Pharmacology & Therapeutics Jg. 110 (2021) Nr. 4, S. 1025 - 1037Online Volltext: dx.doi.org/ (Open Access)
-
A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemiaIn: European Journal of Medical Genetics (EJMG) Jg. 64 (2021) Nr. 8, 104260Online Volltext: dx.doi.org/
-
BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial cloneIn: Cancer Genetics Jg. 254-255 (2021) S. 70 - 74Online Volltext: dx.doi.org/ (Open Access)
-
Eye tumors in childhood as first sign of tumor predisposition syndromes : Insights from an observational study conducted in Germany and AustriaIn: Cancers Jg. 13 (2021) Nr. 8, S. 1876Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Far from Health : The Bone Marrow Microenvironment in AML, A Leukemia Supportive ShelterIn: Children Jg. 8 (2021) Nr. 5, 371Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Impact of kmt2a rearrangement and cspg4 expression in pediatric acute myeloid leukemiaIn: Cancers Jg. 13 (2021) Nr. 19, 4817Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic IndicatorsIn: Blood Cancer Discovery Jg. 2 (2021) Nr. 6, S. 586 - 599Online Volltext: dx.doi.org/ (Open Access)
-
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma : Practical GuidanceIn: Pediatric Drugs Jg. 23 (2021) Nr. 6, S. 537 - 548Online Volltext: dx.doi.org/ (Open Access)
-
Molekulare Tumortherapie : Phase-I/II-Netzwerkstruktur der Gesellschaft für Pädiatrische Onkologie und HämatologieIn: Der Onkologe Jg. 27 (2021) Nr. 5, S. 447 - 457Online Volltext: dx.doi.org/
-
Pediatric Cancer Data Commons : Federating and Democratizing Data for Childhood Cancer ResearchIn: JCO Clinical Cancer Informatics (JCO CCI) Jg. 5 (2021) S. 1034 - 1043Online Volltext: dx.doi.org/ (Open Access)
-
Recommendations for Diagnosis and Treatment of Children with Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia in Down Syndrome (ML-DS)In: Klinische Pädiatrie Jg. 233 (2021) Nr. 06, S. 267 - 277Online Volltext: dx.doi.org/
-
Redirecting the immune microenvironment in acute myeloid leukemiaIn: Cancers Jg. 13 (2021) Nr. 6, S. 1423Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Second relapse of pediatric patients with acute myeloid leukemia : A report on current treatment strategies and outcome of the AML-BFM study groupIn: Cancers Jg. 13 (2021) Nr. 4, S. 789Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Survival following relapse in children with acute myeloid leukemia : A report from aml-bfm and cogIn: Cancers Jg. 13 (2021) Nr. 10, S. 2336Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The Pediatric Precision Oncology INFORM Registry : Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsIn: Cancer Discovery Jg. 11 (2021) Nr. 11, S. 2764 - 2779Online Volltext: dx.doi.org/ (Open Access)
-
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - Presentation of the CARE for CAYA-Program study protocol and associated literature reviewIn: BMC Cancer Jg. 20 (2020) Nr. 1, 16Online Volltext: dx.doi.org/ (Open Access)
-
Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trialIn: Leukemia Jg. 34 (2020) S. 1486Online Volltext: dx.doi.org/ (Open Access)
-
Early deaths from childhood cancer in Germany 1980-2016In: Cancer Epidemiology Jg. 65 (2020) 101669Online Volltext: dx.doi.org/
-
Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnosticsIn: Annals of Hematology Jg. 99 (2020) Nr. 3, S. 459 - 475Online Volltext: dx.doi.org/
-
Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia ModelIn: Molecular Cancer Research Jg. 18 (2020) Nr. 10, S. 1603 - 1612Online Volltext: dx.doi.org/ (Open Access)
-
Genotyping circulating tumor DNA of pediatric Hodgkin lymphomaIn: Leukemia Jg. 34 (2020) Nr. 1, S. 151 - 166Online Volltext: dx.doi.org/
-
Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trialIn: Leukemia Jg. 34 (2020) Nr. 2, S. 613 - 624Online Volltext: dx.doi.org/
-
Insights into the limitations of transient expression systems for the functional study of p53 acetylation site and oncogenic mutantsIn: Biochemical and Biophysical Research Communications (BBRC) Jg. 524 (2020) Nr. 4, S. 990 - 995Online Volltext: dx.doi.org/
-
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemiaIn: British Journal of Haematology Jg. 190 (2020) Nr. 2, S. 198 - 208Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia : a retrospective I-BFM analysis of 333 childrenIn: British Journal of Haematology Jg. 189 (2020) Nr. 4, S. 745 - 750Online Volltext: dx.doi.org/ (Open Access)
-
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents : ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationIn: European Journal of Cancer (EJC) Jg. 136 (2020) S. 116 - 129Online Volltext: dx.doi.org/ (Open Access)
-
Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid LeukemiaIn: HemaSphere: Open Access Journal of the European Hematology Association Jg. 4 (2020) Nr. 1, S. e312Online Volltext: dx.doi.org/ (Open Access)
-
Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN) : a protocol for a multicenter longitudinal prospective observational studyIn: BMC Pediatrics Jg. 20 (2020) Nr. 1, S. 48Online Volltext: dx.doi.org/ (Open Access)
-
Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome : a Single-Center ExperienceIn: Hemoglobin Jg. 44 (2020) Nr. 2, S. 71 - 77Online Volltext: dx.doi.org/
-
Detection of AML-specific mutations in pediatric patient plasma using extracellular vesicle–derived RNAIn: Annals of Hematology Jg. 98 (2019) Nr. 3, S. 595 - 603Online Volltext: dx.doi.org/
-
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia : a report by Berlin-Frankfurt-Münster study groupIn: Haematologica / The Hematology Journal Jg. 104 (2019) Nr. 1, S. 120 - 127Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down SyndromeIn: Cancer Cell Jg. 36 (2019) Nr. 2, S. 123 - 138.e10Online Volltext: dx.doi.org/ (Open Access)
-
Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid LeukemiaIn: Journal of Oncology (2019) 1609128Online Volltext: dx.doi.org/ (Open Access)
-
Phase 1–2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemiaIn: British Journal of Haematology Jg. 186 (2019) Nr. 3, S. e7 - e11Online Volltext: dx.doi.org/ (Open Access)
-
Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumorsIn: Pediatric Blood and Cancer Jg. 66 (2019) Nr. 10, e27900Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Akute Promyelozyten-Leukämie : Neue Behandlungsstrategien mit ATRA und ATO – AML-BFM-EmpfehlungenIn: Klinische Pädiatrie Jg. 230 (2018) Nr. 6, S. 299 - 304Online Volltext: dx.doi.org/
-
An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemiaIn: British Journal of Haematology Jg. 181 (2018) Nr. 4, S. 523 - 527Online Volltext: dx.doi.org/ (Open Access)
-
Cardio-toxicity in childhood cancer survivors “Cure is not enough”In: Journal of Thoracic Disease Jg. 10 (2018) S. S4344 - S4350Online Volltext: dx.doi.org/ (Open Access)
-
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia : A phase IB studyIn: Haematologica / The Hematology Journal Jg. 103 (2018) Nr. 9, S. 1484 - 1492Online Volltext: dx.doi.org/ (Open Access)
-
Endogenous tumor suppressor microRNA-193b : Therapeutic and prognostic value in acute myeloid leukemiaIn: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 10, S. 1007 - 1016Online Volltext: dx.doi.org/ (Open Access)
-
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemiaIn: Blood Jg. 132 (2018) Nr. 3, S. 264 - 276Online Volltext: dx.doi.org/ (Open Access)
-
Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome : TMD Prevention 2007 studyIn: Blood Advances Jg. 2 (2018) Nr. 13, S. 1532 - 1540Online Volltext: dx.doi.org/ (Open Access)
-
Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion productsIn: Scientific Reports Jg. 8 (2018) Nr. 1, S. 2185Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML : a retrospective study by the I-BFM Study GroupIn: Blood Jg. 132 (2018) Nr. 15, S. 1584 - 1592Online Volltext: dx.doi.org/ (Open Access)
-
Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemiaIn: Pediatric Blood and Cancer Jg. 65 (2018) Nr. 2, S. e26848Online Volltext: dx.doi.org/
-
Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALLIn: Blood Advances Jg. 2 (2018) Nr. 12, S. 1382 - 1385Online Volltext: dx.doi.org/ (Open Access)
-
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012In: Leukemia Jg. 32 (2018) S. 2167 - 2177Online Volltext: dx.doi.org/ (Open Access)
-
The genetic basis and cell of origin of mixed phenotype acute leukaemiaIn: Nature Jg. 562 (2018) Nr. 7727, S. 373 - 379Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Two cancer-predisposing variants in one family : Incidental finding of a fumarate hydrogenase (FH) germline variant in a family with Li–Fraumeni syndromeIn: Pediatric Blood and Cancer Jg. 65 (2018) Nr. 10, e27254Online Volltext: dx.doi.org/
-
A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girlIn: Leukemia and Lymphoma Jg. 58 (2017) Nr. 3, S. 718 - 721Online Volltext: dx.doi.org/
-
A specific dietary intervention to restore brain structure and function after ischemic strokeIn: Theranostics Jg. 7 (2017) Nr. 2, S. 493 - 512Online Volltext: dx.doi.org/ (Open Access)
-
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groupsIn: Pediatric Blood and Cancer Jg. 64 (2017) Nr. 12, S. e26664Online Volltext: dx.doi.org/ (Open Access)
-
Childhood cancer predisposition syndromes : A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyIn: American Journal of Medical Genetics, Part A Jg. 173 (2017) Nr. 4, S. 1017 - 1037Online Volltext: dx.doi.org/
-
Feasibility and Toxicity of Simultaneously Administrated Chemotherapy and Proton Therapy in Children and Adolescents
49th Congress of the International Society of Paediatric Oncology (SIOP), October 12–15, 2017, Washington, DC, USA,In: Pediatric Blood and Cancer Jg. 64 (2017) Nr. Suppl. 3, S. S339Online Volltext: dx.doi.org/ -
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidIn: Pediatric Blood and Cancer Jg. 64 (2017) Nr. 8, e26461Online Volltext: dx.doi.org/
-
Genotype-outcome correlations in pediatric AML : the impact of a monosomal karyotype in trial AML-BFM 2004In: Leukemia Jg. 31 (2017) Nr. 12, S. 2807 - 2814Online Volltext: dx.doi.org/ (Open Access)
-
Lowe-dose cytarabine treatment in children with down syndrome and transient Myeloproferative disorder to prevent ML-DS : AML-BFM TMD Prevention 2007 StudyIn: Haematologica / The Hematology Journal Jg. 102 (2017) Nr. Suppl. 2, S. 322 - 322
-
Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomesIn: Nature Genetics Jg. 49 (2017) Nr. 3, S. 451 - 456Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyIn: Annals of Hematology Jg. 96 (2017) Nr. 9, S. 1449 - 1456Online Volltext: dx.doi.org/
-
The non-coding RNA landscape of human hematopoiesis and leukemiaIn: Nature Communications Jg. 8 (2017) Nr. 1, S. 218Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Therapy reduction in patients with Down syndrome and myeloid leukemia : the international ML-DS 2006 trialIn: Blood Jg. 129 (2017) Nr. 25, S. 3314 - 3321Online Volltext: dx.doi.org/ (Open Access)
-
Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groupsIn: Cancer Jg. 122 (2016) Nr. 24, S. 3821 - 3830Online Volltext: dx.doi.org/ (Open Access)
-
Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid LeukemiaIn: Pediatric Blood and Cancer Jg. 63 (2016) Nr. 2, S. 242 - 247Online Volltext: dx.doi.org/
-
Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemiaIn: Expert Review of Anticancer Therapy Jg. 16 (2016) Nr. 2, S. 137 - 146Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation der spezialisierten ambulanten pädiatrischen Palliativversorgung in Niedersachsen – Eine qualitative Studie zur ElternsichtIn: Das Gesundheitswesen Jg. 78 (2016) Nr. 5, S. 306 - 312Online Volltext: dx.doi.org/
-
Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and LeukostasisIn: Pediatric Blood and Cancer Jg. 63 (2016) Nr. 4, S. 640 - 645Online Volltext: dx.doi.org/
-
Hematologic Response to Vorinostat Treatment in Relapsed Myeloid Leukemia of Down SyndromeIn: Pediatric Blood and Cancer Jg. 63 (2016) Nr. 9, S. 1677 - 1679Online Volltext: dx.doi.org/
-
Identification of a Cryptic Insertion ins(11;X)(q23;q28q12) Resulting in a KMT2A-FLNA Fusion in a 13-Month-Old Child with Acute Myelomonocytic LeukemiaIn: Cytogenetics and Cell Genetics Jg. 150 (2016) Nr. 3-4, S. 281 - 286Online Volltext: dx.doi.org/
-
Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome : Analysis of the Prospective Multicenter Trial AML-BFM 2004In: Pediatric Blood and Cancer Jg. 63 (2016) Nr. 6, S. 1070 - 1074Online Volltext: dx.doi.org/
-
Infectious complications in children with acute myeloid leukemia : decreased mortality in multicenter trial AML-BFM 2004In: Blood Cancer Journal Jg. 6 (2016) S. e382Online Volltext: dx.doi.org/ (Open Access)
-
Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia : An Analysis of the AML-BFM 2004 TrialIn: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. 23, S. 2776 - 2783Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Leukämien im KindesalterIn: Der Onkologe Jg. 22 (2016) Nr. 12, S. 923 - 932Online Volltext: dx.doi.org/
-
MIR-139-5p controls translation in myeloid leukemia through EIF4G2In: Oncogene Jg. 35 (2016) Nr. 14, S. 1822 - 1831Online Volltext: dx.doi.org/
-
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemiaIn: OncoTarget Jg. 7 (2016) Nr. 30, S. 48412 - 48422Online Volltext: dx.doi.org/ (Open Access)
-
Netzwerk für onkologische Fachberatung (NOF) – Modellprojekt für (Langzeit-) Nachsorge nach einer Krebserkrankung im Kindes- und JugendalterIn: Klinische Pädiatrie Jg. 228 (2016) Nr. 06/07, S. 325 - 331Online Volltext: dx.doi.org/
-
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyIn: European Journal of Cancer (EJC) Jg. 65 (2016) S. 91 - 101Online Volltext: dx.doi.org/
-
Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapiesIn: Gene Therapy Jg. 23 (2016) Nr. 7, S. 615 - 626Online Volltext: dx.doi.org/
-
PHF6 mutations in paediatric acute myeloid leukaemiaIn: British Journal of Haematology Jg. 175 (2016) Nr. 5, S. 967 - 971Online Volltext: dx.doi.org/
-
Pädiatrische Onkologie : Behandlungsstrukturen und aktuelle HerausforderungenIn: Der Onkologe Jg. 22 (2016) Nr. 12, S. 904 - 907Online Volltext: dx.doi.org/
-
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL : a retrospective intergroup studyIn: Blood Jg. 127 (2016) Nr. 26, S. 3424 - 3430Online Volltext: dx.doi.org/ (Open Access)
-
Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survivalIn: Leukemia Jg. 29 (2015) Nr. 11, S. 2260 - 2263Online Volltext: dx.doi.org/
-
Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML : Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study GroupIn: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 36, S. 4247 - 4258Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid LeukemiaIn: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 27, S. 2949 - 2962Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Family History and Relapse in Pediatric Acute Myeloid LeukemiaIn: Pediatric Blood and Cancer Jg. 62 (2015) Nr. 12, S. 2235 - 2237Online Volltext: dx.doi.org/
-
Gene Expression Profiles Associated with Pediatric Relapsed AMLIn: PLoS ONE Jg. 10 (2015) Nr. 4, S. e0121730Online Volltext: dx.doi.org/ (Open Access)
-
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia : a retrospective international studyIn: Blood Jg. 126 (2015) Nr. 13, S. 1575 - 1584Online Volltext: dx.doi.org/ (Open Access)
-
Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trialIn: Annals of Hematology Jg. 94 (2015) Nr. 8, S. 1327 - 1336Online Volltext: dx.doi.org/ (Open Access)
-
Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic LeukemiaIn: Klinische Pädiatrie Jg. 227 (2015) Nr. 6 / 7, S. 329 - 334Online Volltext: dx.doi.org/
-
Prospective Validation of a New Method of Monitoring Minimal Residual Disease in Childhood Acute Myelogenous LeukemiaIn: Clinical Cancer Research Jg. 21 (2015) Nr. 6, S. 1353 - 1359Online Volltext: dx.doi.org/
-
Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML – Results from Study AML-BFM 2004In: Klinische Pädiatrie Jg. 227 (2015) Nr. 3, S. 116 - 122Online Volltext: dx.doi.org/
-
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemiaIn: Haematologica / The Hematology Journal Jg. 100 (2015) Nr. 9, S. 1151 - 1159Online Volltext: dx.doi.org/ (Open Access)
-
Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL-FNBP1 fusion geneIn: Leukemia and Lymphoma Jg. 56 (2015) Nr. 3, S. 793 - 796Online Volltext: dx.doi.org/
-
Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemiasIn: International Journal of Hematology Jg. 102 (2015) Nr. 1, S. 140 - 143Online Volltext: dx.doi.org/
-
Subtype prediction in pediatric acute myeloid leukemia : classification using differential network rank conservation revisitedIn: BMC Bioinformatics Jg. 16 (2015) S. 305Online Volltext: dx.doi.org/ (Open Access)
-
Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapseIn: British Journal of Haematology Jg. 166 (2014) Nr. 6, S. 902 - 910Online Volltext: dx.doi.org/
-
Re-induction with L-DNR/FLAG improves response after AML relapse, but not long-term survivalIn: Klinische Pädiatrie Jg. 226 (2014) Nr. 6-7, S. 323 - 331Online Volltext: dx.doi.org/
-
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia : results of the international study Relapsed AML 2001/01In: Haematologica / The Hematology Journal Jg. 99 (2014) Nr. 9, S. 1472 - 1478Online Volltext: dx.doi.org/ (Open Access)
-
Allo-SCT using BU, CY and melphalan for children with AML in second CRIn: Bone Marrow Transplantation Jg. 48 (2013) Nr. 5, S. 651 - 656Online Volltext: dx.doi.org/
-
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: Results from study AML-BFM 2004In: Blood Jg. 122 (2013) Nr. 1, S. 37 - 43Online Volltext: dx.doi.org/
-
Favorable outcome in infants with AML after intensive first- and second-line treatment: An AML-BFM study group reportIn: Leukemia Jg. 26 (2012) Nr. 4, S. 654 - 661Online Volltext: dx.doi.org/ (Open Access)
-
The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: Results from the AML-BFM 98 studyIn: Haematologica Jg. 97 (2012) Nr. 1, S. 21 - 29Online Volltext: dx.doi.org/ (Open Access)
-
CNS irradiation in pediatric acute myleoid leukemia : equal results by 12 or 18 Gy in studies AML-BFM98 and 2004In: Pediatric Blood and Cancer Jg. 57 (2011) Nr. 6, S. 986 - 992Online Volltext: dx.doi.org/
-
Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline dosesIn: British Journal of Haematology Jg. 149 (2010) Nr. 3, S. 399 - 409Online Volltext: dx.doi.org/
-
Real-time PCR-based post-transplant monitoring of haematopoietic chimerism : an option for earlier detection of impending relapse in paediatric AMLIn: Bone Marrow Transplantation Jg. 45 (2010) Nr. Suppl. 2, S. S263Online Volltext: dx.doi.org/
-
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effectiveIn: Bone Marrow Transplantation Jg. 33 (2004) Nr. 8, S. 815 - 821Online Volltext: dx.doi.org/
-
Collaborative data sharing : The International Acute Myeloid Leukemia Consortium (INTERACT)
ASCO Breakthrough: A Global Summit for Oncology Innovators; AUG 08-10, 2024; Yokohama, Japan,In: Journal of Clinical Oncology (JCO) Jg. 42 (2024) Nr. Suppl. 23, S. 169 - 169Online Volltext: dx.doi.org/ -
AML-derived small EVs containing YBX1 influences mesenchymal stromal cells differentiation in the bone marrow niche
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 31.05 – 03.06.2023, Wilsede, Germany,In: Klinische Pädiatrie Jg. 235 (2023) Nr. 3, S. 192Online Volltext: dx.doi.org/ -
Characteristics of FLT3-ITD and Efficacy of Sorafenib Treatment in Pediatric AML : A Report from AML-BFM Study GroupIn: Blood Jg. 142 (2023) Nr. Supplement 1: Annual Meeting Abstracts (65th ASH Annual Meeting and Exposition, 9-12 Dezember 2023, San Diego), S. 4217 - 4217Online Volltext: dx.doi.org/ (Open Access)
-
Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 31.05. – 03.06.2023, Wilsede, Germany,In: Klinische Pädiatrie Jg. 235 (2023) Nr. 3, S. 194 - 195Online Volltext: dx.doi.org/ -
Hyperparathyroidism is associated with inferior event free survival in lymphatic childhood malignancies in a single center retrospective analysisIn: Hormone Research in Paediatrics Jg. 96 (2023) Nr. Suppl. 4, S. 134
-
Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 31.05 – 03.06.2023, Wilsede, Germany,In: Klinische Pädiatrie Jg. 235 (2023) Nr. 3, S. 197Online Volltext: dx.doi.org/ -
Nucleophosmin (NPM1) Type D Genotype Is Associated with Distinct Outcome in Acute Myeloid Leukemia - an AIEOP-BFM and COG-SWOG Intergroup Collaboration
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 840 - 841Online Volltext: dx.doi.org/ (Open Access) -
Treatment of Molecular Relapses in Pediatric AML Saves Toxicities Prior to Hematopoietic Stem Cell Transplantation (HSCT) : Results of AMoRe2017 Trial
65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 1521 - 1521Online Volltext: dx.doi.org/ (Open Access) -
A randomised clinical phase 2 trial to compare treosulfan with busulfan based conditioning prior to allogeneic haematopoietic stem cell transplantation in children with non-malignant diseasesIn: Bone Marrow Transplantation Jg. 57 (2022) Nr. Suppl. 1, S. 91 - 92
-
Diagnostic and functional role of extracellular vesicles (EV) from blood and CSF in pediatric medulloblastoma (MB)
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 01.-04.06.2022, Wilsede, Germany,In: Klinische Pädiatrie Jg. 234 (2022) Nr. 3, S. 183Online Volltext: dx.doi.org/ -
Downregulation of the Mutated WT1 Alleles in Malignant Hematopoietic Cells Via Nonsense-Mediated mRNA Decay Contradicts Their Prognostic Impact
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 11498 - 11499Online Volltext: dx.doi.org/ (Open Access) -
Guiding Pups with Severe Hemophilia a and Their Parents from Diagnosis to a Full Prophylactic Schedule Mitigating the Risk of Bleed and the Risk for Inhibitor Formation : a Single Centre ApproachIn: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 8472 - 8473Online Volltext: dx.doi.org/ (Open Access)
-
ITCC-101/APAL2020D : A Randomized Phase 3 Trial of Fludarabine/Cytarabine/Gemtuzumab Ozogamycin with or without Venetoclax in Children with Relapsed Acute Myeloid Leukemia
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 3369 - 3370Online Volltext: dx.doi.org/ (Open Access) -
Identification and isolation of homogenous AML derived extracellular vesicles for MRD detection in pediatric AML
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 01.-04.06.2022, Wilsede, Germany,In: Klinische Pädiatrie Jg. 234 (2022) Nr. 3, S. 182Online Volltext: dx.doi.org/ -
Molecular Relapse in Pediatric AML : Clinical Relapse May be Predicted By Increasingin MRD Level - Experiences from Real-World Data in Patients with Inv(16), t(8;21), t(9;11), t(10;11) or NPM1
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 6326 - 6327Online Volltext: dx.doi.org/ (Open Access) -
RAS Pathway Alterations in Pediatric AML PatientsIn: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 6110 - 6111Online Volltext: dx.doi.org/ (Open Access)
-
Rearrangements Involving 11q23/KMT2A : Mutational Landscape and Prognostic Implications ; Results of the Harmony Alliance AML Database
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1, S. 551 - 554Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Revision of Complete Remission Criteria in Pediatric AML
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 1016 - 1017Online Volltext: dx.doi.org/ (Open Access) -
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics
34. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung ; 01.–04.06.2022, Wilsede, Germany,In: Klinische Pädiatrie Jg. 234 (2022) Nr. 3, S. 186Online Volltext: dx.doi.org/ -
Voxelotor bei Jugendlichen und Erwachsenen mit Sichelzellkrankheit : erste Erfahrungen aus dem deutschen Härtefallprogramm
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 48Online Volltext: dx.doi.org/ (Open Access) -
A Phase 1, Dose-Escalation Study of Gilteritinib Combined with Chemotherapy in Patients aged 6 Months to <21 Years with FLT3 Internal Tandem Duplication-Positive Relapsed or Refractory AML
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 2315 - 2317Online Volltext: dx.doi.org/ (Open Access) -
An Individualized Approach to Treating Pups with Severe Hemophilia a : Which Factors Correlate with the Low Rate of Inhibitor Development?
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 2106 - 2107Online Volltext: dx.doi.org/ (Open Access) -
Does RAD21 Co-Mutation Have a Role in DNMT3A Mutated AML? Results of Harmony Alliance AML Database
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 608 - 611Online Volltext: dx.doi.org/ (Open Access) -
Harmony Alliance Provides a Machine Learning Researching Tool to Predict the Risk of Relapse after First Remission in AML Patients Treated without Allogeneic Haematopoietic Stem Cell Transplantation
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 4041 - 4044Online Volltext: dx.doi.org/ (Open Access) -
Impact of Gender on Molecular AML Subclasses : a Harmony Alliance Study
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3438 - 3441Online Volltext: dx.doi.org/ (Open Access) -
Improved Outcome in Pediatric De Novo AML - Results of The AML-BFM 2012 Trial
53rd Congress of the international Society of Paediatric Oncology (SIOP), Virtual Congress, October 21-24, 2021,In: Pediatric Blood and Cancer Jg. 68 (2021) Nr. S5, S. S91Online Volltext: dx.doi.org/ (Open Access) -
Myeloid Leukemia Dependencies at CTCF-Enriched Long Noncoding RNA Loci
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 500 - 502Online Volltext: dx.doi.org/ (Open Access) -
A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumorsIn: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 15_Suppl., S. 10535Online Volltext: dx.doi.org/
-
Sickle Cell Disease (SCD) : a single-centre experience - update
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 180 - 181Online Volltext: dx.doi.org/ (Open Access) -
Impact of a Risk-Adapted Treatment Approach in Pediatric AML : A Report of the AML-BFM Registry 2012
Konferenz 61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 293Online Volltext: dx.doi.org/ (Open Access) -
Induction of a Leukemic Bone Marrow Niche Mediated By TGFB1 of Leukemic Blasts in Pediatric Acute Mekaryoblastic Leukemia : Results of an in Vitro and In Vivo Analysis
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 3734 - 3734Online Volltext: dx.doi.org/ (Open Access) -
Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses
61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 918Online Volltext: dx.doi.org/ (Open Access) -
Mutational Landscape of Pediatric Acute Myeloid Leukemia : A Report of the AML-BFM Study Group with a Targeted NGS Approach in 525 Patients Integrating De Novo, Relapsed and Secondary AML
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 1398 - 1398Online Volltext: dx.doi.org/ (Open Access) -
Phase II Study of Midostaurin + Chemotherapy in Pediatric Patients with Untreated, Newly Diagnosed, FLT3-Mutated Acute Myeloid Leukemia (AML)
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 3835 - 3835Online Volltext: dx.doi.org/ (Open Access) -
Treatment‐Related Acute Myeloid Leukemia in Children
61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1: 61st ASH Annual Meeting, S. 1322 - 1322Online Volltext: dx.doi.org/ (Open Access) -
Hypodiploidy in Childhood Acute Myeloid Leukemia : A Retrospective Cohort Study within the International Berlin-Frankfurt-Münster Study GroupIn: Blood Jg. 132 (2018) Nr. Supplement 1, 60th ASH Annual Meeting Abstracts, S. 1466 - 1466Online Volltext: dx.doi.org/ (Open Access)
-
Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 2754 - 2754Online Volltext: dx.doi.org/ (Open Access) -
Modelling the Progression of a Preleukemic Stage to Overt Leukemia in Children with Down Syndrome
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 543 - 543Online Volltext: dx.doi.org/ (Open Access) -
Mimicking The Bone Marrow Niche IN VITRO : Establishment Of A 3D Perfusion Culture System for Mesenchymal Stromal Cells
ACUTE LEUKEMIAS XV : Biology and Treatment Strategies, February 22– 25, 2015, Munich, Germany,,In: Annals of Hematology Jg. 94 (2015) Nr. Suppl. 1, S. 85Online Volltext: dx.doi.org/ -
Whole Exome Sequencing in Single Cells from Pediatric Patients with Acute Myeloid Leukemia and NPM1/Flt3 Mutations
ACUTE LEUKEMIAS XV : Biology and Treatment Strategies, February 22– 25, 2015, Munich, Germany,In: Annals of Hematology Jg. 94 (2015) Nr. Suppl. 1, S. 76Online Volltext: dx.doi.org/ -
De Novo AMLIn: Acute Myeloid Leukemia in Children / Tomizawa, Daisuke; Kolb, Edward Anders; Reinhardt, Dirk (Hrsg.) 2024, S. 105 - 122Online Volltext: dx.doi.org/
-
Diagnosis and Classifications of Pediatric AMLIn: Acute Myeloid Leukemia in Children / Tomizawa, Daisuke; Kolb, Edward Anders; Reinhardt, Dirk (Hrsg.) 2024, S. 59 - 77Online Volltext: dx.doi.org/
-
Clinical use of clofarabine for adults and children with leukemiaIn: Chemotherapy for Leukemia: Novel Drugs and Treatment / Ueda, Takanori (Hrsg.) 2017, S. 287 - 309Online Volltext: dx.doi.org/
-
APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 1492 - 1493Online Volltext: dx.doi.org/ (Open Access) -
Europeanpediatric Acute Leukemia (EuPAL) Registry
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 1496 - 1497Online Volltext: dx.doi.org/ (Open Access) -
An Individualized Approach to Treating Pups with Severe Hemophilia A
15th Annual Congress of European Association for Haemophilia and Allied Disorders 2022, 2–4 February 2022, Virtual,In: Haemophilia Jg. 28 (2022) Nr. S1: Special Issue:15th Annual Congress of European Association for Haemophilia and Allied Disorders 2022, 2–4 February 2022, Virtual Meeting, S. 37 - 37Online Volltext: dx.doi.org/ (Open Access) -
Long-Term Follow-up of AML Patients Treated Intensively before the Era of Targeted Agents : a Big Data Analysis from the Harmony Collaboration
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 6053 - 6055Online Volltext: dx.doi.org/ (Open Access) -
Management and Outcome of Hyperleukocytosis As Early Complication in Childhood AML : an AML-BFM Experience
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1: Annual Meeting Abstracts, S. 6084 - 6085Online Volltext: dx.doi.org/ (Open Access) -
RUNX1 Mutations Have Distinct Prognostic and Clinical Implication in Pediatric AML : Results of the AML-BFM Study Group
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1: Annual Meeting Abstracts, S. 9110 - 9112Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Second Malignancy after Childhood AML Treatment : a Retrospective Analysis of the AML-BFM Stud
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 6082 - 6083Online Volltext: dx.doi.org/ (Open Access) -
Trial in Progress: eine multizentrische Open-label Phase IB/ II Studie zur Bestimmung der Dosierung und Sicherheit von Asciminib bei pädiatrischen Patienten mit chronischer myeloischer Leukämie in der chronischen Phase (ASC4kids)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 301Online Volltext: dx.doi.org/ (Open Access) -
Unexpected severe toxicity of crizotinib in combination with vinblastine : the crisp open-label phase 1B trial in pediatric patients with anaplastic large cell lymphoma (ALCL) (ITCC-053)
54th Congress of the International Society of Paediatric Oncology (SIOP), September 28 – October 1, 2022,In: Pediatric Blood and Cancer Jg. 69 (2022) Nr. Suppl. 5, S. S321Online Volltext: dx.doi.org/ -
Modification of total nodal Irradiation (TNI) as Part of Conditioning prior to allogeneic Stem Cell Transplantation (aSCT) for hematological Diseases using helical Tomotherapy or IMRT based on a retrospective Cohort
27. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, DEGRO 2021, virtuell,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1: Abstracts DEGRO 2021, S. S173Online Volltext: dx.doi.org/ -
Modular Exercise Program (MEP) in Pediatric Oncology for Intensity-Driven Exercise Control - Feasibility in Hematopoietic Stem Cell Transplantation
53rd Congress of the international Society of Paediatric Oncology (SIOP), Virtual Congress, October 21-24, 2021,In: Pediatric Blood and Cancer Jg. 68 (2021) Nr. S5, S. S348Online Volltext: dx.doi.org/ (Open Access) -
Modifikation der total nodalen Bestrahlung (TNI) als Teil der Konditionierung vor allogener Stammzelltransplantation (aSZT) bei hämatologischen Erkrankungen mittels helikaler Tomotherapie anhand einer retrospektiven Kohorte
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S105Online Volltext: dx.doi.org/ (Open Access)